CYTH

Cyclo Therapeutics, Inc. [CYTH] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CYTH Stock Summary

Top 10 Correlated ETFs

CYTH

Top 10 Correlated Stocks

CYTH

In the News

CYTH Financial details

Company Rating

Market Cap

36.18M

Income

-20.06M

Revenue

1.08M

Book val./share

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

13 May 2024

P/E

-1.25

Forward P/E

PEG

0.45

P/S

35.64

P/B

-22.92

P/C

P/FCF

-2.32

Quick Ratio

0.32

Current Ratio

0.83

Debt / Equity

LT Debt / Equity

EPS (TTM)

-1.31

EPS next Y

EPS next Q

EPS this Y

-32.04%

EPS next Y

EPS next 5Y

EPS last 5Y

-29.55%

Revenue last 5Y

1.34%

Revenue Q/Q

-37.15%

EPS Q/Q

-20.69%

SMA20

-8.54%

SMA50

22.95%

SMA100

Inst Own

Inst Trans

ROA

-343%

ROE

3430%

ROC

18.9%

Gross Margin

91%

Oper. Margin

-2036%

Profit Margin

-2020%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.68-2.57

52W High

52W Low

RSI

43.69

Rel Volume

0.14

Avg Volume

111.05K

Volume

15.15K

Perf Week

-4.29%

Perf Month

-9.14%

Perf Quarter

15%

Perf Half Y

8.24%

Beta

-0.152

Volatility

0.02%, 0.11%

Prev Close

-2.13%

Price

0.736

Change

3.66%

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 111.05K
Market Capitalization 36.18M
Employee 8
CEO Mr. N. Scott Fine
Headquarters Gainesville,FL,US
IPO Date 2000-05-03
Website https://www.cyclotherapeutics.com

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.